One preliminary study suggests CBD may help to fight Covid-19
Further studies will be required to verify the research and facilitate the creation of CBD-centric solutions suitable for Covid-19 patients.
GW Pharmaceuticals’ cannabis-derived epilepsy drug wins European approval
The European Commission approved GW Pharma's Epidyolex as a treatment for seizures in two rare and severe forms of epilepsy. The drug won FDA approval last year.
What Are Healthcare Organizations Getting Wrong about Email Security?
A new report by Paubox calls for healthcare IT leaders to dispose of outdated assumptions about email security and address the challenges of evolving cybersecurity threats.
Sandoz gets into the weeds with cannabis medical product manufacturer Tilray
The Canadian company's shares reached a high price after it signed a framework agreement with Novartis's generics arm that would enable global commercialization.
GW Pharmaceuticals gets first FDA approval for CBD-based drug
The FDA approved the cannabis-based drug for treating seizures in two severe forms of epilepsy.
5 companies mixing medicine and marijuana
From eye drops for glaucoma to chewing gum for irritable bowel syndrome, derivatives of cannabis are making their way into FDA trials in pursuit of a biotech/pharma market projected to reach $20 billion by 2020.